BioAscent Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
77
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
BioAscent General Information
Description
Provider of integrated drug discovery services intended to reach key stages of the drug discovery process. The company offers a range of services, including target analysis, bespoke screening strategies, compound screening, and data management, enabling pharmaceutical businesses to maximize their lead findings and increase the success rate of discovery projects at a lower cost.
Contact Information
Website
www.bioascent.comCorporate Office
- BioCity Bo'ness Road
- Newhouse Lanarkshire
- Motherwell ML1 5UH
- Scotland, United Kingdom
Corporate Office
- BioCity Bo'ness Road
- Newhouse Lanarkshire
- Motherwell ML1 5UH
- Scotland, United Kingdom
BioAscent Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 01-Apr-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 19-Jun-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
BioAscent Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
BioAscent Comparisons
Industry
Financing
Details
BioAscent Competitors (15)
One of BioAscent’s 15 competitors is Ubiquigent, a Venture Capital-Backed company based in Dundee, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ubiquigent | Venture Capital-Backed | Dundee, United Kingdom | ||||
| Selvita | Corporation | Krakow, Poland | ||||
| Aragen Life Sciences | Private Equity-Backed | Hyderabad, India | ||||
| OMass Therapeutics | Venture Capital-Backed | Oxford, United Kingdom | ||||
| Charles River Laboratories International | Formerly PE-Backed | Wilmington, MA |
BioAscent Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BioAscent Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BioAscent Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Pioneer Group | Venture Capital | Minority | ||
| Maven Capital Partners UK | PE/Buyout | Minority |
BioAscent Investments (1)
BioAscent’s most recent deal was a Corporate Asset Purchase with BioAscent (Chemogenomic Compound Library in Motherwell, United Kingdom). The deal was made on 21-May-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BioAscent (Chemogenomic Compound Library in Motherwell, United Kingdom) | 21-May-2025 | Corporate Asset Purchase | Buildings and Property |
BioAscent FAQs
-
When was BioAscent founded?
BioAscent was founded in 2013.
-
Where is BioAscent headquartered?
BioAscent is headquartered in Motherwell, United Kingdom.
-
What is the size of BioAscent?
BioAscent has 77 total employees.
-
What industry is BioAscent in?
BioAscent’s primary industry is Drug Discovery.
-
Is BioAscent a private or public company?
BioAscent is a Private company.
-
What is BioAscent’s current revenue?
The current revenue for BioAscent is .
-
How much funding has BioAscent raised over time?
BioAscent has raised $2.13M.
-
Who are BioAscent’s investors?
Pioneer Group and Maven Capital Partners UK have invested in BioAscent.
-
Who are BioAscent’s competitors?
Ubiquigent, Selvita, Aragen Life Sciences, OMass Therapeutics, and Charles River Laboratories International are some of the 15 competitors of BioAscent.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
